These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

198 related items for PubMed ID: 24532519

  • 1. Risk factors and molecular epidemiology of community-onset extended-spectrum β-lactamase-producing Escherichia coli bacteremia.
    Park YS, Bae IK, Kim J, Jeong SH, Hwang SS, Seo YH, Cho YK, Lee K, Kim JM.
    Yonsei Med J; 2014 Mar; 55(2):467-75. PubMed ID: 24532519
    [Abstract] [Full Text] [Related]

  • 2. Emergence of extended-spectrum β-lactamase-producing escherichia coli as a cause of community-onset bacteremia in South Korea: risk factors and clinical outcomes.
    Park SH, Choi SM, Lee DG, Kim J, Choi JH, Kim SH, Kwon JC, Yoo JH.
    Microb Drug Resist; 2011 Dec; 17(4):537-44. PubMed ID: 21875342
    [Abstract] [Full Text] [Related]

  • 3. Community-onset bacteremia due to extended-spectrum beta-lactamase-producing Escherichia coli: risk factors and prognosis.
    Rodríguez-Baño J, Picón E, Gijón P, Hernández JR, Ruíz M, Peña C, Almela M, Almirante B, Grill F, Colomina J, Giménez M, Oliver A, Horcajada JP, Navarro G, Coloma A, Pascual A, Spanish Network for Research in Infectious Diseases (REIPI).
    Clin Infect Dis; 2010 Jan 01; 50(1):40-8. PubMed ID: 19995215
    [Abstract] [Full Text] [Related]

  • 4. Clinical and molecular epidemiology of community-onset bacteremia caused by extended-spectrum β-lactamase-producing Escherichia coli over a 6-year period.
    Kang CI, Cha MK, Kim SH, Ko KS, Wi YM, Chung DR, Peck KR, Lee NY, Song JH.
    J Korean Med Sci; 2013 Jul 01; 28(7):998-1004. PubMed ID: 23853481
    [Abstract] [Full Text] [Related]

  • 5. Escherichia coli producing SHV-type extended-spectrum beta-lactamase is a significant cause of community-acquired infection.
    Rodríguez-Baño J, Alcalá J, Cisneros JM, Grill F, Oliver A, Horcajada JP, Tórtola T, Mirelis B, Navarro G, Cuenca M, Esteve M, Peña C, Llanos AC, Cantón R, Pascual A.
    J Antimicrob Chemother; 2009 Apr 01; 63(4):781-4. PubMed ID: 19223299
    [Abstract] [Full Text] [Related]

  • 6. Risk Factors and Molecular Features of Sequence Type (ST) 131 Extended-spectrum β-Lactamase-producing Escherichia coli in Community-onset Bacteremia.
    Kim H, Kim YA, Park YS, Choi MH, Lee GI, Lee K.
    Sci Rep; 2017 Nov 07; 7(1):14640. PubMed ID: 29116143
    [Abstract] [Full Text] [Related]

  • 7. Risk factors for community-onset urinary tract infections due to Escherichia coli harbouring extended-spectrum beta-lactamases.
    Calbo E, Romaní V, Xercavins M, Gómez L, Vidal CG, Quintana S, Vila J, Garau J.
    J Antimicrob Chemother; 2006 Apr 07; 57(4):780-3. PubMed ID: 16492721
    [Abstract] [Full Text] [Related]

  • 8. Bacteremia due to extended-spectrum beta -lactamase-producing Escherichia coli in the CTX-M era: a new clinical challenge.
    Rodríguez-Baño J, Navarro MD, Romero L, Muniain MA, de Cueto M, Ríos MJ, Hernández JR, Pascual A.
    Clin Infect Dis; 2006 Dec 01; 43(11):1407-14. PubMed ID: 17083012
    [Abstract] [Full Text] [Related]

  • 9. Risk factors for community-onset urinary tract infections caused by extended-spectrum β-lactamase-producing Escherichia coli.
    Tüzün T, Sayın Kutlu S, Kutlu M, Kaleli İ.
    Turk J Med Sci; 2019 Aug 08; 49(4):1206-1211. PubMed ID: 31385490
    [Abstract] [Full Text] [Related]

  • 10. Bacteremia caused by extended-spectrum-β-lactamase-producing Escherichia coli sequence type ST131 and non-ST131 clones: comparison of demographic data, clinical features, and mortality.
    Chung HC, Lai CH, Lin JN, Huang CK, Liang SH, Chen WF, Shih YC, Lin HH, Wang JL.
    Antimicrob Agents Chemother; 2012 Feb 08; 56(2):618-22. PubMed ID: 22123694
    [Abstract] [Full Text] [Related]

  • 11. Molecular characteristics of extended-spectrum beta-lactamase-producing Escherichia coli from the Chicago area: high prevalence of ST131 producing CTX-M-15 in community hospitals.
    Peirano G, Costello M, Pitout JD.
    Int J Antimicrob Agents; 2010 Jul 08; 36(1):19-23. PubMed ID: 20359869
    [Abstract] [Full Text] [Related]

  • 12. Outcomes and risk factors for mortality in community-onset bacteremia caused by extended-spectrum beta-lactamase-producing Escherichia coli, with a special emphasis on antimicrobial therapy.
    Kang CI, Wi YM, Ko KS, Chung DR, Peck KR, Lee NY, Song JH.
    Scand J Infect Dis; 2013 Jul 08; 45(7):519-25. PubMed ID: 23509913
    [Abstract] [Full Text] [Related]

  • 13. Molecular epidemiology of extended-spectrum β-lactamase-producing Escherichia coli in the community and hospital in Korea: emergence of ST131 producing CTX-M-15.
    Park SH, Byun JH, Choi SM, Lee DG, Kim SH, Kwon JC, Park C, Choi JH, Yoo JH.
    BMC Infect Dis; 2012 Jun 29; 12():149. PubMed ID: 22747570
    [Abstract] [Full Text] [Related]

  • 14. [Prevalence and risk factors for extended-spectrum β-lactamase-producing Escherichia coli causing community-onset urinary tract infections in Colombia].
    Blanco VM, Maya JJ, Correa A, Perenguez M, Muñoz JS, Motoa G, Pallares CJ, Rosso F, Matta L, Celis Y, Garzon M, Villegas MV.
    Enferm Infecc Microbiol Clin; 2016 Nov 29; 34(9):559-565. PubMed ID: 26774256
    [Abstract] [Full Text] [Related]

  • 15. Risk factors and molecular epidemiology of community-onset, multidrug resistance extended-spectrum β-lactamase-producing Escherichia coli infections.
    Park SY, Kang CI, Wi YM, Chung DR, Peck KR, Lee NY, Song JH.
    Korean J Intern Med; 2017 Jan 29; 32(1):146-157. PubMed ID: 27093979
    [Abstract] [Full Text] [Related]

  • 16. Epidemiology and risk factors for isolation of Escherichia coli producing CTX-M-type extended-spectrum β-lactamase in a large U.S. Medical Center.
    Hayakawa K, Gattu S, Marchaim D, Bhargava A, Palla M, Alshabani K, Gudur UM, Pulluru H, Bathina P, Sundaragiri PR, Sarkar M, Kakarlapudi H, Ramasamy B, Nanjireddy P, Mohin S, Dasagi M, Datla S, Kuchipudi V, Reddy S, Shahani S, Upputuri V, Marrey S, Gannamani V, Madhanagopal N, Annangi S, Sudha B, Muppavarapu KS, Moshos JA, Lephart PR, Pogue JM, Bush K, Kaye KS.
    Antimicrob Agents Chemother; 2013 Aug 29; 57(8):4010-8. PubMed ID: 23752516
    [Abstract] [Full Text] [Related]

  • 17. Molecular epidemiology and clinical features of extended-spectrum beta-lactamase- or carbapenemase-producing Escherichia coli bacteremia in Japan.
    Komatsu Y, Kasahara K, Inoue T, Lee ST, Muratani T, Yano H, Kirita T, Mikasa K.
    PLoS One; 2018 Aug 29; 13(8):e0202276. PubMed ID: 30157275
    [Abstract] [Full Text] [Related]

  • 18. Epidemiology and risk factors of community onset infections caused by extended-spectrum β-lactamase-producing Escherichia coli strains.
    Kang CI, Wi YM, Lee MY, Ko KS, Chung DR, Peck KR, Lee NY, Song JH.
    J Clin Microbiol; 2012 Feb 29; 50(2):312-7. PubMed ID: 22162561
    [Abstract] [Full Text] [Related]

  • 19. Risk factors and prognosis of nosocomial bloodstream infections caused by extended-spectrum-beta-lactamase-producing Escherichia coli.
    Rodríguez-Baño J, Picón E, Gijón P, Hernández JR, Cisneros JM, Peña C, Almela M, Almirante B, Grill F, Colomina J, Molinos S, Oliver A, Fernández-Mazarrasa C, Navarro G, Coloma A, López-Cerero L, Pascual A.
    J Clin Microbiol; 2010 May 29; 48(5):1726-31. PubMed ID: 20181897
    [Abstract] [Full Text] [Related]

  • 20. Risk factors and outcomes in non-transplant patients with extended-spectrum beta-lactamase-producing Escherichia coli bacteremia: a retrospective study from 2013 to 2016.
    Xiao T, Yang K, Zhou Y, Zhang S, Ji J, Ying C, Shen P, Xiao Y.
    Antimicrob Resist Infect Control; 2019 May 29; 8():144. PubMed ID: 31467670
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.